Shanghai Kehua Bio-engineering Subsidiary Receives Two IVD Certificates from NMPA
CompanyMedical Device

Shanghai Kehua Bioengineering Subsidiary Receives Two IVD Certificates from NMPA

Shenzhen Beimei's TWYNEO Receives NMPA Clinical Trial Approval for Acne Treatment
CompanyDrug

Shenzhen Beimei’s TWYNEO Receives NMPA Clinical Trial Approval for Acne Treatment

Chison Medical and Gates Foundation Collaborate on Innovative Ultrasound Equipment
CompanyDeals

Chison Medical and Gates Foundation Collaborate on Innovative Ultrasound Equipment

Shanghai MicroPort EP MedTech's IceMagic Catheter Receives EU MDR Certification
CompanyMedical Device

Shanghai MicroPort EP MedTech’s IceMagic Catheter Receives EU MDR Certification

CTTQ Doses First Patient in China for TQB6411 Phase I Clinical Trial
CompanyDrug

CTTQ Doses First Patient in China for TQB6411 Phase I Clinical Trial

FDA-Approved Smile System Launches in Lecheng for ADHD Treatment
CompanyDrug

FDA-Approved Smile System Launches in Lecheng for ADHD Treatment

Grand Pharma’s TLX591 Granted NMPA Approval for Phase III Prostate Cancer Trial
CompanyDrug

Grand Pharma’s TLX591 Granted NMPA Approval for Phase III Prostate Cancer Trial

Abbisko Therapeutics Completes First Patient Dosing for PRMT5×MTA Inhibitor ABSK131
CompanyDrug

Abbisko Therapeutics Completes First Patient Dosing for PRMT5×MTA Inhibitor ABSK131

Novatim and ERIGEN Ink Licensing Pact for Dual-Target CAR-T Therapy KQ-2003
CompanyDeals

Novatim and ERIGEN Ink Licensing Pact for Dual-Target CAR-T Therapy KQ-2003

AusperBio Gains NMPA Approval for Phase III Trials of AHB-137 in Chronic Hepatitis B
CompanyDrug

AusperBio Gains NMPA Approval for Phase III Trials of AHB-137 in Chronic Hepatitis B

Sanofi to Acquire Vicebio Ltd for Up to USD 1.6 Billion, Advancing Next-Gen Vaccine Development
CompanyDeals

Sanofi to Acquire Vicebio Ltd for Up to USD 1.6 Billion, Advancing Next-Gen Vaccine Development

AstraZeneca to Invest $50 Billion in US Manufacturing and R&D Expansion by 2030
Company

AstraZeneca to Invest $50 Billion in US Manufacturing and R&D Expansion by 2030